Pyelonephritis Drug Market
Pyelonephritis Drug Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Pyelonephritis Drug Market Size and Growth
The Pyelonephritis drug market is experiencing growth driven by increasing prevalence of urinary tract infections and advancements in therapeutic options. The market is projected to reach approximately $1.5 billion by 2030, supported by rising healthcare expenditures and innovative drug developments, enhancing treatment efficacy and patient outcomes in managing kidney infections.
Companies Covered
(Covid 19 Impact Covered)
◍ Achaogen Inc
◍ AstraZeneca Plc
◍ Meiji Seika Pharma Co Ltd
◍ Merck & Co Inc
◍ MerLion Pharmaceuticals Pte Ltd
◍ The Medicines Company
◍ Zavante Therapeutics Inc
The Pyelonephritis drug market is competitive, with companies like Achaogen, AstraZeneca, and Merck focusing on novel antibiotics and therapies. These firms enhance market growth through innovative product development and strategic collaborations. Sales revenue figures include AstraZeneca at $29 billion and Merck at $48 billion, reflecting strong market presence.
Request Sample Report
Market Segmentation
By Application
Hospital
Clinic
Others
By Product
◍ Finafloxacin
Fosfomycin Tromethamine
Nacubactam
Plazomicin Sulfate
Others
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
